Children with obsessive-compulsive disorder: Are they just "little adults"?

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 737-746

  Kalra, Simran K ^a   Swedo, Susan E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PAROXETINE; PIMOZIDE; PLACEBO; RILUZOLE; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANOREXIA; ANXIETY DISORDER; APATHY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPULSION; DIARRHEA; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; HUMAN; HYPOMANIA; INSOMNIA; NAUSEA; NEUROIMAGING; NEUROIMMUNOLOGY; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEDATION; SEROTONIN SYNDROME; SEX RATIO; SIDE EFFECT; TREMOR; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADULT; BASAL GANGLION; BIOLOGICAL MODEL; BRAIN; CHILD; FEMALE; MALE; NERVE CELL NETWORK; UNITED STATES;

ADOLESCENT; ADULT; BASAL GANGLIA; BRAIN; CHILD; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MODELS, NEUROLOGICAL; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER; UNITED STATES;

EID: 65249105977     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37563     Document Type: Review

References (124)

1. American Psychiatric Association and American Psychiatric Association Task Force on DSM-IV. 2000. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association. Washington, DC, USA. 943 pp.
2. Leckman, J.F., et al. 1997. Symptoms of obsessivecompulsive disorder. Am. J. Psychiatry. 154:911-917.
3. Goodman, W.K., et al. 1989. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch. Gen. Psychiatry. 46:1006-1011.
4. Poyurovsky, M., Faragian, S., Shabeta, A., and Kosov, A. 2008. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 159:133-139.
5. Storch, E.A., et al. 2008. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr. Psychiatry. 49:35-42.
6. Karno, M., Golding, J.M., Sorenson, S.B., and Burnam, M.A. 1988. The epidemiology of obsessivecompulsive disorder in five US communities. Arch. Gen. Psychiatry. 45:1094-1099.
7. Swedo, S.E., Rapoport, J.L., Leonard, H., Lenane, M., and Cheslow, D. 1989. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch. Gen. Psychiatry. 46:335-341.
8. Eisen, J.L., et al. 1998. The Brown Assessment of Beliefs Scale: reliability and validity. Am. J. Psychiatry. 155:102-108.
9. Storch, E.A., et al. 2008. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 160:212-220.
10. Tumkaya, S., et al. 2009. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison. Psychiatry Res. 165:38-46.
11. Leonard, H.L., et al. 1992. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am. J. Psychiatry. 149:1244-1251.
12. Castle, D.J., Deale, A., and Marks, I.M. 1995. Gender differences in obsessive compulsive disorder. Aust. N. Z. J. Psychiatry. 29:114-117.
13. Mancebo, M.C., et al. 2008. Juvenile-onset OCD: clinical features in children, adolescents and adults. Acta Psychiatr. Scand. 118:149-159.
14. Bloch, M.H., Landeros-Weisenberger, A., Rosario, M.C., Pittenger, C., and Leckman, J.F. 2008. Metaanalysis of the symptom structure of obsessive-compulsive disorder. Am. J. Psychiatry. 165:1532-1542.
15. Bloch, M.H., Leckman, J.F., Zhu, H., and Peterson, B.S. 2005. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology. 65:1253-1258.
16. Geller, E., et al. 1998. Rasmussen encephalitis: complementary role of multitechnique neuroimaging. AJNR Am. J. Neuroradiol. 19:445-449.
17. Pauls, D.L., Alsobrook, J.P., 2nd, Goodman, W., Rasmussen, S., and Leckman, J.F. 1995. A family study of obsessive-compulsive disorder. Am. J. Psychiatry. 152:76-84.
18. Eichstedt, J.A., and Arnold, S.L. 2001. Childhoodonset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin. Psychol. Rev. 21:137-157.
19. Busatto, G.F., et al. 2001. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. J. Am. Acad. Child Adolesc. Psychiatry. 40:347-354.
20. Pauls, D.L. 2008. The genetics of obsessive compulsive disorder: a review of the evidence. Am J. Med. Genet. C Semin. Med. Genet. 148:133-139.
21. Jonnal, A.H., Gardner, C.O., Prescott, C.A., and Kendler, K.S. 2000. Obsessive and compulsive symptoms in a general population sample of female twins. Am. J. Med. Genet. 96:791-796.
22. van Grootheest, D.S., Cath, D.C., Beekman, A.T., and Boomsma, D.I. 2005. Twin studies on obsessive-compulsive disorder: a review. Twin Res. Hum. Genet. 8:450-458.
23. Arnold, P.D., Sicard, T., Burroughs, E., Richter, M.A., and Kennedy, J.L. 2006. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch. Gen. Psychiatry. 63:769-776.
24. Stewart, S.E., et al. 2007. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J. Med. Genet. B Neuropsychiatr. Genet. 144B:1027-1033.
25. Fireman, B., Koran, L.M., Leventhal, J.L., and Jacobson, A. 2001. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am. J. Psychiatry. 158:1904-1910.
26. Leonard, H.L., et al. 2001. Obsessive-compulsive disorder and related conditions. Pediatr. Ann. 30:154-160.
27. Geller, D.A. 2006. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr. Clin. North Am. 29:353-370.
28. Weissman, M.M., et al. 1994. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J. Clin. Psychiatry. 55(Suppl.):5-10.
29. Robins, L., Helzer, J., Crougham, J., and Ratcliffe., K. 1981. The NIMH Epidemiological Catchment Area study. Arch. Gen. Psychiatry. 38:381-389.
30. Karno, M., and Golding, J. 1990. Obsessive-compulsive disorder. In Psychiatric disorders in America: the Epidemiologic Catchment Area Study. L.N. Robins and D.A. Regier, editors. The Free Press. New York, New York, USA. 204-219.
31. Wittchen, H.U., Nelson, C.B., and Lachner, G. 1998. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol. Med. 28:109-126.
32. Douglass, H.M., Moffitt, T.E., Dar, R., McGee, R., and Silva, P. 1995. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J. Am. Acad. Child Adolesc. Psychiatry. 34:1424-1431.
33. Flament, M.F., et al. 1988. Obsessive compulsive disorder in adolescence: an epidemiological study. J. Am. Acad. Child Adolesc. Psychiatry. 27:764-771.
34. Zohar, A.H. 1999. The epidemiology of obsessivecompulsive disorder in children and adolescents. Child Adolesc. Psychiatr. Clin. N. Am. 8:445-460.
35. Stewart, S.E., et al. 2004. Long-term outcome of pediatric obsessive-compulsive disorder: a metaanalysis and qualitative review of the literature. Acta Psychiatr. Scand. 110:4-13.
36. Pediatric OCD Treatment Study (POTS) Team. 2004. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 292:1969-1976.
37. Rapoport, J.L., and Inoff-Germain, G. 2000. Treatment of obsessive-compulsive disorder in children and adolescents. J. Child Psychol. Psychiatry. 41:419-431.
38. Storch, E.A., et al. 2007. Family-based cognitivebehavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J. Am. Acad. Child Adolesc. Psychiatry. 46:469-478.
39. Barrett, P., Healy-Farrell, L., and March, J.S. 2004. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J. Am. Acad. Child Adolesc. Psychiatry. 43:46-62.
40. Baer, L., and Greist, J.H. 1997. An interactive computer-administered self-assessment and self-help program for behavior therapy. J. Clin. Psychiatry. 58(Suppl. 12):23-28.
41. Simpson, H.B., et al. 2008. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am. J. Psychiatry. 165:621-630.
42. March, J.S., and Mulle, K. 1998. OCD in children and adolescents: a cognitive-behavioral treatment manual. Guilford Press. New York, New York, USA. 298 pp.
43. Piacentini, J. 1999. Cognitive behavioral therapy of childhood OCD. Child Adolesc. Psychiatr. Clin. N. Am. 8:599-616.
44. Freeman, J.B., et al. 2008. Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J. Am. Acad. Child Adolesc. Psychiatry. 47:593-602.
45. Leonard, H.L., et al. 1989. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A doubleblind crossover comparison. Arch. Gen. Psychiatry. 46:1088-1092.
46. [No authors listed]. 1991. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch. Gen. Psychiatry. 48:730-738.
47. Geller, D.A., et al. 2003. Which SSRI? A metaanalysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am. J. Psychiatry. 160:1919-1928.
48. Grados, M., Scahill, L., and Riddle, M.A. 1999. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc. Psychiatr. Clin. N. Am. 8:617-634, x.
49. McDougle, C.J. 1997. Update on pharmacologic management of OCD: agents and augmentation. J. Clin. Psychiatry. 58(Suppl. 12):11-17.
50. March, J.S., et al. 2007. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol. Psychiatry. 61:344-347.
51. Grados, M., and Riddle, M.A. 2008. Do all obsessive-compulsive disorder subtypes respond to medication? Int. Rev. Psychiatry. 20:189-193.
52. Storch, E.A., et al. 2008. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry. 47:583-592.
53. March, J.S., and Curry, J.F. 1998. Predicting the outcome of treatment. J. Abnorm. Child Psychol. 26:39-51.
54. Riddle, M.A., et al. 2001. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J. Am. Acad. Child Adolesc. Psychiatry. 40:222-229.
55. Vasa, R.A., Carlino, A.R., and Pine, D.S. 2006. Pharmacotherapy of depressed children and adolescents: current issues and potential directions. Biol. Psychiatry. 59:1021-1028.
56. March, J.S., Klee, B.J., and Kremer, C.M. 2006. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. J. Child. Adolesc. Psychopharmacol. 16:91-102.
57. Hollander, E., Kaplan, A., and Stahl, S.M. 2003. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J. Biol. Psychiatry. 4:30-34.
58. Pigott, T.A., L'Heureux, F., and Rubenstein, C. 1992. A controlled trial of clonazepam augmentation in OCD patients tested with clomipramine or fluoxetine [abstract no. 144]. Presented at the 145th Annual Meeting of the American Psychiatric Association. May 2-7. Washington, DC, USA. T.A. Pigott, editor. American Psychiatric Association. Washington, DC, USA. 82 pp.
59. Leonard, H.L., et al. 1994. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry. 33:792-794.
60. Skapinakis, P., Papatheodorou, T., and Mavreas, V. 2007. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessivecompulsive disorder: a meta-analysis of the randomized controlled trials. Eur. Neuropsychopharmacol. 17:79-93.
61. Saxena, S., Wang, D., Bystritsky, A., and Baxter, L.R., Jr. 1996. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J. Clin. Psychiatry. 57:303-306.
62. Bloch, M.H., et al. 2006. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol. Psychiatry. 11:622-632.
63. McDougle, C.J., et al. 1994. Haloperidol addition in fluvoxamine- refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch. Gen. Psychiatry. 51:302-308.
64. Matsunaga, H., et al. 2002. Obsessive-compulsive disorder with poor insight. Compr. Psychiatry. 43:150-157.
65. Lombroso, P.J., et al. 1995. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J. Am. Acad. Child Adolesc. Psychiatry. 34:1147-1152.
66. Coric, V., et al. 2005. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol. Psychiatry. 58:424-428.
67. Grant, P., Lougee, L., Hirschtritt, M., and Swedo, S.E. 2007. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J. Child Adolesc. Psychopharmacol. 17:761-767.
68. Von Economo, C. 1931. Encephalitis lethargica: its sequelae and treatment. Oxford University Press. London, United Kingdom. 200 pp.
69. Saxena, S., and Rauch, S.L. 2000. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr. Clin. North Am. 23:563-586.
70. Saxena, S., Brody, A.L., Schwartz, J.M., and Baxter, L.R. 1998. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry Suppl. 35:26-37.
71. Schwartz, J.M., Stoessel, P.W., Baxter, L.R., Jr., Martin, K.M., and Phelps, M.E. 1996. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry. 53:109-113.
72. Baxter, L.R., Jr., et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry. 49:681-689.
73. Smith, Y., Hazrati, L.N., and Parent, A. 1990. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J. Comp. Neurol. 294:306-323.
74. Baxter, L.R., Jr., et al. 1996. Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and nonhuman primate. Semin. Clin. Neuropsychiatry. 1:32-47.
75. Rosenberg, D.R., and Keshavan, M.S. 1998. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol. Psychiatry. 43:623-640.
76. Chamberlain, S.R., et al. 2008. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science. 321:421-422.
77. Menzies, L., et al. 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofrontostriatal model revisited. Neurosci. Biobehav. Rev. 32:525-549.
78. Alexander, G.E., DeLong, M.R., and Strick, P.L. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:357-381.
79. Cummings, J.L., and Cunningham, K. 1992. Obsessive-compulsive disorder in Huntington's disease. Biol. Psychiatry. 31:263-270.
80. Rasmussen, S.A., and Eisen, J.L. 1997. Treatment strategies for chronic and refractory obsessivecompulsive disorder. J. Clin. Psychiatry. 58(Suppl. 13):9-13.
81. Christensen, D.D., Laitinen, L.V., Schmidt, L.J., and Hariz, M.I. 2002. Anterior capsulotomy for treatment of refractory obsessive-compulsive disorder: results in a young and an old patient. Stereotact. Funct. Neurosurg. 79:234-244.
82. Greenberg, B.D., Murphy, D.L., and Rasmussen, S.A. 2000. Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. Psychiatr. Clin. North Am. 23:671-686, xii.
83. Szeszko, P.R., et al. 2008. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am. J. Psychiatry. 165:1299-1307.
84. Szeszko, P.R., et al. 2004. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am. J. Psychiatry. 161:1049-1056.
85. Perani, D., et al. 1995. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiatry. 166:244-250.
86. Maltby, N., Tolin, D.F., Worhunsky, P., O'Keefe, T.M., and Kiehl, K.A. 2005. Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. Neuroimage. 24:495-503.
87. Ananth, J., Pecknold, J.C., van den Steen, N., and Engelsmann, F. 1981. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog. Neuropsychopharmacol. 5:257-262.
88. Insel, T.R., Mueller, E.A., Alterman, I., Linnoila, M., and Murphy, D.L. 1985. Obsessive-compulsive disorder and serotonin: is there a connection? Biol. Psychiatry. 20:1174-1188.
89. DeVeaugh-Geiss, J., Katz, R., Landau, P., Goodman, W., and Rasmussen, S. 1990. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol. Bull. 26:54-59.
90. Goddard, A.W., Shekhar, A., Whiteman, A.F., and McDougle, C.J. 2008. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov. Today. 13:325-332.
91. Bastani, B., Nash, J.F., and Meltzer, H.Y. 1990. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 47:833-839.
92. Zohar, J., Mueller, E.A., Insel, T.R., Zohar-Kadouch, R.C., and Murphy, D.L. 1987. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch. Gen. Psychiatry. 44:946-951.
93. Zohar, J., Insel, T.R., Zohar-Kadouch, R.C., Hill, J.L., and Murphy, D.L. 1988. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Arch. Gen. Psychiatry. 45:167-172.
94. Pigott, T.A., et al. 1991. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol. Psychiatry. 29:418-426.
95. Frye, P.E., and Arnold, L.E. 1981. Persistent amphetamine-induced compulsive rituals: response to pyridoxine(B6). Biol. Psychiatry. 16:583-587.
96. Goodman, W.K., et al. 1990. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J. Clin. Psychiatry. 51(Suppl.):36-43; discussion 55-38.
97. Stein, D.J., Bouwer, C., Hawkridge, S., and Emsley, R.A. 1997. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J. Clin. Psychiatry. 58:119-122.
98. Storch, E.A., Lehmkuhl, H., Geffken, G.R., Touchton, A., and Murphy, T.K. 2008. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress. Anxiety. 25:172-174.
99. van der Wee, N.J., et al. 2004. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. Am. J. Psychiatry. 161:2201-2206.
100. Swedo, S., and Rapoport, J.L. 1990. Neurochemical and neuroendocrine consideration of obsessivecompulsive disorder in childhood. In Application of basic neuroscience to child psychiatry. Plenum Medical Books. New York, New York, USA. 275-284.
101. Chakrabarty, K., Bhattacharyya, S., Christopher, R., and Khanna, S. 2005. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. 30:1735-1740.
102. Zald, D.H., and Kim, S.W. 1996. Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry; and obsessive-compulsive disorder. J. Neuropsychiatry. Clin. Neurosci. 8:125-138.
103. Garvey, M.A., Giedd, J., and Swedo, S.E. 1998. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J. Child Neurol. 13:413-423.
104. Budman, C.L., Kerjakovic, M., and Bruun, R.D. 1997. Viral infection and tic exacerbation. J. Am. Acad. Child Adolesc. Psychiatry. 36:162.
105. Ercan, T.E., Ercan, G., Severge, B., Arpaozu, M., and Karasu, G. 2008. Mycoplasma pneumoniae infection and obsessive-compulsive disease: a case report. J. Child Neurol. 23:338-340.
106. Riedel, M., Straube, A., Schwarz, M.J., Wilske, B., and Muller, N. 1998. Lyme disease presenting as Tourette's syndrome. Lancet. 351:418-419.
107. Swedo, S.E., et al. 1993. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics. 91:706-713.
108. Swedo, S.E., et al. 1998. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry. 155:264-271.
109. Kiessling, L.S., Marcotte, A.C., and Culpepper, L. 1994. Antineuronal antibodies: tics and obsessive-compulsive symptoms. J. Dev. Behav. Pediatr. 15:421-425.
110. Kirvan, C.A., Swedo, S.E., Snider, L.A., and Cunningham, M.W. 2006. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J. Neuroimmunol. 179:173-179.
111. Hamilton, C.S., Garvey, M.A., and Swedo, S.E. 2001. Therapeutic implications of immunology for tics and obsessive-compulsive disorder. Adv. Neurol. 85:311-318.
112. Hallett, J.J., Harling-Berg, C.J., Knopf, P.M., Stopa, E.G., and Kiessling, L.S. 2000. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J. Neuroimmunol. 111:195-202.
113. Taylor, J.R., et al. 2002. An animal model of Tourette's syndrome. Am. J. Psychiatry. 159:657-660.
114. Singer, H.S., et al. 1998. Antibodies against human putamen in children with Tourette syndrome. Neurology. 50:1618-1624.
115. Morshed, S.A., et al. 2001. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol. Psychiatry. 50:566-577.
116. Liu, X., Wang, Y., Li, D., and Ju, X. 2008. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav. Brain Res. 186:84-90.
117. Kirvan, C.A., Swedo, S.E., Heuser, J.S., and Cunningham, M.W. 2003. Mimicry and autoantibodymediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9:914-920.
118. Garvey, M.A., et al. 1999. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol. Psychiatry. 45:1564-1571.
119. Snider, L.A., Lougee, L., Slattery, M., Grant, P., and Swedo, S.E. 2005. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol. Psychiatry. 57:788-792.
120. Perlmutter, S.J., et al. 1999. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 354:1153-1158.
121. Giedd, J.N., Rapoport, J.L., Leonard, H.L., Richter, D., and Swedo, S.E. 1996. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J. Am. Acad. Child Adolesc. Psychiatry. 35:913-915.
122. Giedd, J.N., Rapoport, J.L., Garvey, M.A., Perlmutter, S., and Swedo, S.E. 2000. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry. 157:281-283.
123. Elia, J., et al. 2005. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J. Am. Acad. Child Adolesc. Psychiatry. 44:1145-1150.
124. Martin, A. 2003. Pediatric psychopharmacology: principles and practice. Oxford University Press. Oxford, United Kingdom/New York, New York, USA. 175-181.